Mr. Northcott brings over 20 years of biopharmaceutical experience building commercial organizations and successfully commercializing novel products, including BTK inhibitor ibrutinib
Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer
Seeking Alpha / 8 hours ago 1 Views
Mr. Northcott brings over 20 years of biopharmaceutical experience building commercial organizations and successfully commercializing novel products, including BTK inhibitor ibrutinib
Comments